Kathryn A. Tworkoski, Ph.D.
Affiliations: | 2013 | Experimental Pathology | Yale University, New Haven, CT |
Area:
Molecular Biology, Pathology, OncologyGoogle:
"Kathryn Tworkoski"Parents
Sign in to add mentor| David Frederick Stern | grad student | 2013 | Yale | |
| (Analysis of the melanoma kinome: The role of the Axl and Mer receptor tyrosine kinases in melanoma pathogenesis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tworkoski K, Raab-Traub N. (2015) LMP1 Promotes Expression of Insulin-Like Growth Factor 1 (IGF1) To Selectively Activate IGF1 Receptor and Drive Cell Proliferation Journal of Virology. 89: 2590-2602 |
| Tworkoski KA, Platt JT, Bacchiocchi A, et al. (2013) MERTK controls melanoma cell migration and survival and differentially regulates cell behavior relative to AXL. Pigment Cell & Melanoma Research. 26: 527-41 |
| Tworkoski K, Singhal G, Szpakowski S, et al. (2011) Phosphoproteomic screen identifies potential therapeutic targets in melanoma. Molecular Cancer Research : McR. 9: 801-12 |
| Godshalk SE, Paranjape T, Nallur S, et al. (2011) A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma. Oncogene. 30: 1542-50 |